Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashutosh D Wechalekar

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
JACC. Cardiooncology|November 3, 2021
The Evolving Epidemiology of AmyloidosisAshutosh D Wechalekar
Blood|April 7, 2018
Biomarkers in AL amyloidosis: is the summit in sight?Ashutosh D Wechalekar
Blood|October 25, 2011
ASCT for AL: all's well that ends wellAshutosh D Wechalekar
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|November 7, 2015
Role of imaging in cardiac amyloidosis: An ongoing challengeAshutosh D Wechalekar
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 21, 2020
Wild-type transthyretin cardiac amyloidosis: When is a rare disease no longer a rare disease?Kshama Wechalekar, Ashutosh D Wechalekar
Blood|May 4, 2022
Daratumumab in AL amyloidosisAshutosh D Wechalekar, Vaishali Sanchorawala
British Medical Bulletin|July 31, 2013
Imaging in systemic amyloidosisSajitha Sachchithanantham, Ashutosh D Wechalekar
Leukemia|April 10, 2020
Systemic amyloidosis: moving into the spotlightOliver C Cohen, Ashutosh D Wechalekar
Oncology (Williston Park, N.Y.)|April 12, 2012
AL amyloidosis: new drugs and tests, but old challengesAshutosh D Wechalekar, Philip N Hawkins
Hematology/Oncology Clinics of North America|October 25, 2020
Systemic Amyloidosis due to Low-Grade LymphomaAshutosh D Wechalekar, Raj Chakraborty, Suzanne Lentzsch
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
JACC. Cardiooncology|November 3, 2021
The Evolving Epidemiology of AmyloidosisAshutosh D Wechalekar
Blood|April 7, 2018
Biomarkers in AL amyloidosis: is the summit in sight?Ashutosh D Wechalekar
Blood|October 25, 2011
ASCT for AL: all's well that ends wellAshutosh D Wechalekar
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|November 7, 2015
Role of imaging in cardiac amyloidosis: An ongoing challengeAshutosh D Wechalekar
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 21, 2020
Wild-type transthyretin cardiac amyloidosis: When is a rare disease no longer a rare disease?Kshama Wechalekar, Ashutosh D Wechalekar
Blood|May 4, 2022
Daratumumab in AL amyloidosisAshutosh D Wechalekar, Vaishali Sanchorawala
British Medical Bulletin|July 31, 2013
Imaging in systemic amyloidosisSajitha Sachchithanantham, Ashutosh D Wechalekar
Leukemia|April 10, 2020
Systemic amyloidosis: moving into the spotlightOliver C Cohen, Ashutosh D Wechalekar
Oncology (Williston Park, N.Y.)|April 12, 2012
AL amyloidosis: new drugs and tests, but old challengesAshutosh D Wechalekar, Philip N Hawkins
Hematology/Oncology Clinics of North America|October 25, 2020
Systemic Amyloidosis due to Low-Grade LymphomaAshutosh D Wechalekar, Raj Chakraborty, Suzanne Lentzsch
Pageof 17